Ozagrel

Ozagrel

Systematic (IUPAC) name
(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
Legal status	℞ (Prescription only)
Identifiers
CAS Number	82571-53-7
ATC code	none
PubChem	CID 5282440
ChemSpider	4445594
UNII	L256JB984D
KEGG	D08327
ChEMBL	CHEMBL11662
Chemical data
Formula	C13H12N2O2
Molar mass	228.24 g/mol
SMILES C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
InChI InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+ Key:SHZKQBHERIJWAO-AATRIKPKSA-N
(what is this?)  (verify)

Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.^[1]

References

1. Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. PMID 3820396.